Raymond James analyst Andrew Cooper reiterated a Market Perform on Neogenomics (NASDAQ: NEO).The analyst comments "Quick take: This morning NeoGenomics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Neogenomics (NEO) PT Lowered to $17 at BTIGFebruary 19, 2025 2:57 PM Neogenomics (NEO) PT Lowered to $17 at Morgan StanleyFebruary 19, 2025 8:05 AM Neogenomics (NEO) PT Lowered to $18 at NeedhamFebruary 18, 2025 4:01 PM Form 8-K NEOGENOMICS INC For: Feb 18February 18, 2025 7:08 AM NeoGenomics (NEO) Tops Q4 EPS by 1c; offers guidanceFebruary 18, 2025 7:06 AM NeoGenomics Reports Fourth Quarter and Full Year 2024 ResultsFebruary 18, 2025 7:05 AM Form SCHEDULE 13G/A NEOGENOMICS INC Filed by: JANUS HENDERSON GROUP PLCFebruary 14, 2025 11:35 AM